Table of Contents
show
About Unlearn.AI
Unlearn.AI develops a platform to accelerate clinical trials for Alzheimer’s Disease, Multiple Sclerosis, and other complex diseases.
Website: Learn more on Unlearn.AI’s website
Crunchbase: Follow on Crunchbase
[adace-ad id=”4426″]Series A – Unlearn.AI
Amount Raised | 3000000 USD |
Announced Date | 2020-11-05 |
Equity Only Funding | Yes |
Organization Location | San Francisco, California, United States, North America |
Funding Status | Early Stage Venture |
Number of Funding Rounds | 2 |
Lead Investors | |
Number of Investors | 3 |
Number of Partner Investors |